Dextrose Injection
Product Images NDC 0338-0174

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0338-0174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Assembly 1 (Image 01)

FDA Label Image

Assembly Step 2 (Image 02)

FDA Label Image

Assembly Part 3 (Image 03)

FDA Label Image

Reconstitution Step 4 (Image 04)

This text provides instructions on how to reconstitute a substance using a bag and a valve. It advises to only use a dry and sealed valve and to break the seal by bending the bag back and forth until a gap is visible.*

FDA Label Image

Reconstitution Step 5 (Image 05)

This appears to be a set of instructions for adding either liquid or powdered drugs to vials. For liquid drugs, the user is directed to proceed to Step 6. For powdered drugs, they are instructed to hold the bag with the vial in a downward position, squeeze the solution into the vial until it is half full, then shake to suspend the drug in the solution.*

FDA Label Image

Reconstitution Step 6 (Image 06)

FDA Label Image

Dextrose Hydrous Structural Formula (Image 07)

Destrose Hydrous, USP is a type of medication that is available in the US. No further information is available from the given text.*

FDA Label Image

Representative Container 0338-0170-01 (Image 08)

This is a set of instructions on how to use a product that comes with 3 vials of Dexmose solution. The user needs to break the seal and mix before use. There are additional details on dosage and storage temperature but they are not fully readable due to errors. The product is manufactured by Baxter, located in Barre, Hoaurcen, USA.*

FDA Label Image

Representative Container Label 0338-0174-01 (Image 09)

This is a description for an injection solution that contains 5% dextrose. The solution should be mixed after the seal is broken before use. It is manufactured and distributed by Baxter and can be used with a specific medical device. The text also mentions potential side effects and storage instructions.*

FDA Label Image

Representative Container Label 0338-0172-01 (Image 10)

This is a description for an injection solution called 5% Dextrose injection USP which requires one to break the seal and mix before use. It is suitable for use with t VAL, has each 100 milliliters containing 5 percent Dextrose and meets USP Sate S AvomMeTOn AT TR e P Fon WTRORS 15 Do ko s T 1w 100 STunc 4t Roow Taene (35°6) Ao ExcsoneHox i O. The manufacturer is Baxter, located in Bara et Cocmron, Dol G001 USA, and the item is identified by code c8-35-05-008 D.*

FDA Label Image

Representative Container Label 0338-0176-01 (Image 11)

This text contains some instructions for medical use. It mentions a solution called "5% Dextrose Injection USP" and advises to mix it before use. There's also a reference to a product named "84 PLUS Swas D" which is intended to be used with a "200 VAL" (unknown abbreviation). The text includes some measurements and mentions a specific temperature for storage ("35°6"). The text appears to come from Baxter, a healthcare company or laboratory, but further information is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.